These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23751569)

  • 1. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
    Vaccarella S; Lortet-Tieulent J; Plummer M; Franceschi S; Bray F
    Eur J Cancer; 2013 Oct; 49(15):3262-73. PubMed ID: 23751569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
    Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence trends of adenocarcinoma of the cervix in 13 European countries.
    Bray F; Carstensen B; Møller H; Zappa M; Zakelj MP; Lawrence G; Hakama M; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2191-9. PubMed ID: 16172231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in cervical cancer mortality in the Americas.
    Robles SC; White F; Peruga A
    Bull Pan Am Health Organ; 1996 Dec; 30(4):290-301. PubMed ID: 9041740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
    Bray F; Lortet-Tieulent J; Znaor A; Brotons M; Poljak M; Arbyn M
    Vaccine; 2013 Dec; 31 Suppl 7():H32-45. PubMed ID: 24332296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of cervical cancer in Taiwan.
    Wang PD; Lin RS
    Gynecol Oncol; 1996 Sep; 62(3):344-52. PubMed ID: 8812531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
    Simonella L; Canfell K
    Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.
    Arbyn M; Weiderpass E; Bruni L; de Sanjosé S; Saraiya M; Ferlay J; Bray F
    Lancet Glob Health; 2020 Feb; 8(2):e191-e203. PubMed ID: 31812369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
    PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.
    Vaccarella S; Franceschi S; Zaridze D; Poljak M; Veerus P; Plummer M; Bray F
    Lancet Oncol; 2016 Oct; 17(10):1445-1452. PubMed ID: 27567054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer.
    Beral V; Hermon C; Muñoz N; Devesa SS
    Cancer Surv; 1994; 19-20():265-85. PubMed ID: 7534630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of cancer of the cervix: global and national perspective.
    Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K
    J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer in New Zealand: national and regional trends.
    Cox B; Borman B
    N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.